{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T19:22:16Z","timestamp":1720207336609},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"General Research Fund of the Hong Kong University","award":["560211"],"award-info":[{"award-number":["560211"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.toxicon.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T14:09:02Z","timestamp":1429970942000},"page":"42-45","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploration of endogenous substrate cleavage by various forms of botulinum neurotoxins"],"prefix":"10.1016","volume":"100","author":[{"given":"Jiubiao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Waichi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a08","key":"10.1016\/j.toxicon.2015.04.008_bib1","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2015.04.008_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:JOPC.0000016257.91979.06","article-title":"Mapping of the antibody-binding regions on the HN-domain (residues 449-859) of botulinum neurotoxin A with antitoxin antibodies from four host species. Full profile of the continuous antigenic regions of the H-chain of botulinum neurotoxin A","volume":"23","author":"Atassi","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.toxicon.2015.04.008_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A\u00a0novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.toxicon.2015.04.008_bib4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181bb0dbb","article-title":"Botulinum neurotoxin type A injections for vaginismus secondary to vulvar vestibulitis syndrome","volume":"114","author":"Bertolasi","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.toxicon.2015.04.008_bib5","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl."},{"key":"10.1016\/j.toxicon.2015.04.008_bib6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/toxins4100913","article-title":"Clinical uses of Botulinum Neurotoxins: current indications, limitations and future developments","volume":"4","author":"Chen","year":"2012","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2015.04.008_bib7","doi-asserted-by":"crossref","first-page":"25540","DOI":"10.1074\/jbc.M701922200","article-title":"Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E","volume":"282","author":"Chen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2015.04.008_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20101310","article-title":"Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F","volume":"433","author":"Chen","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2015.04.008_bib9","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1074\/jbc.M611211200","article-title":"Mechanism of substrate recognition by botulinum neurotoxin serotype A","volume":"282","author":"Chen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2015.04.008_bib10","doi-asserted-by":"crossref","first-page":"21153","DOI":"10.1074\/jbc.M800611200","article-title":"Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin","volume":"283","author":"Chen","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2015.04.008_bib11","first-page":"227","article-title":"Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients","volume":"78","author":"Cullis","year":"1998","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.toxicon.2015.04.008_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2005.06.001","article-title":"Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins","volume":"28","author":"Davletov","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.toxicon.2015.04.008_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2011.02.002","article-title":"Reduction of antibody response against botulinum neurotoxin A by synthetic monomethoxypolyethylene glycol-peptide conjugates","volume":"137","author":"Dolimbek","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.toxicon.2015.04.008_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"Dover","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.toxicon.2015.04.008_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","article-title":"Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans","volume":"256","author":"Eleopra","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxicon.2015.04.008_bib16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/j.1743-6109.2011.02247.x","article-title":"Different treatment modalities for refractory vaginismus in western Saudi Arabia","volume":"8","author":"Fageeh","year":"2011","journal-title":"J.\u00a0Sex. Med."},{"key":"10.1016\/j.toxicon.2015.04.008_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.toxicon.2009.01.037","article-title":"Engineered toxins: new therapeutics","volume":"54","author":"Foster","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2015.04.008_bib18","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00002508-200211001-00012","article-title":"Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes","volume":"18","author":"Glogau","year":"2002","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.toxicon.2015.04.008_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies\u2013therapeutic consequences","volume":"147","author":"Goschel","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxicon.2015.04.008_bib20","doi-asserted-by":"crossref","first-page":"27881","DOI":"10.1074\/jbc.M113.491134","article-title":"Unique substrate recognition mechanism of the botulinum neurotoxin D light chain","volume":"288","author":"Guo","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2015.04.008_bib21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.toxicon.2013.08.055","article-title":"Engineering Clostridia Neurotoxins with elevated catalytic activity","volume":"74","author":"Guo","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2015.04.008_bib22","first-page":"452","article-title":"The therapeutic potential of botulinum toxin","volume":"30","author":"Klein","year":"2004","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2015.04.008_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1054\/jocn.2000.0684","article-title":"The current use of botulinum toxin","volume":"7","author":"Mahant","year":"2000","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.toxicon.2015.04.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.1994.tb00396.x","article-title":"Mechanism of action of tetanus and botulinum neurotoxins","volume":"13","author":"Montecucco","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.toxicon.2015.04.008_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-013-1380-7","article-title":"The blockade of the neurotransmitter release apparatus by botulinum neurotoxins","volume":"71","author":"Pantano","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2015.04.008_bib26","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10350-005-0179-5","article-title":"Improvement of wound healing after hemorrhoidectomy: a double-blind, randomized study of botulinum toxin injection","volume":"48","author":"Patti","year":"2005","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.toxicon.2015.04.008_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2015.04.008_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/MMBR.56.1.80-99.1992","article-title":"Properties and use of botulinum toxin and other microbial neurotoxins in medicine","volume":"56","author":"Schantz","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.toxicon.2015.04.008_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.59.6.601","article-title":"Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A","volume":"59","author":"Sheean","year":"1995","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2015.04.008_bib30","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in\u00a0vitro","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2015.04.008_bib31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1517\/14656566.5.9.2017","article-title":"Botulinum toxin A for the treatment of cervical dystonia","volume":"5","author":"Zesiewicz","year":"2004","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010115001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010115001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T09:55:36Z","timestamp":1598954136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010115001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"alternative-id":["S0041010115001051"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2015.04.008","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of endogenous substrate cleavage by various forms of botulinum neurotoxins","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}